CLINTON GROUP INC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
CLINTON GROUP INC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q1 2018$2,841,000
+36.7%
178,470
+78.5%
0.30%
+67.6%
Q4 2017$2,078,000
-99.9%
100,000
-31.2%
0.18%
+95.7%
Q1 2017$1,604,005,000
+89911.5%
145,422
+100.4%
0.09%
+12.0%
Q3 2016$1,782,000
-50.0%
72,568
-59.0%
0.08%
-46.8%
Q2 2016$3,563,000
-34.8%
176,927
+229.0%
0.16%
-64.8%
Q4 2015$5,467,000
+82.2%
53,780
+219.7%
0.44%
+56.5%
Q3 2015$3,001,000
+22.7%
16,823
+52.8%
0.28%
-17.3%
Q2 2015$2,446,000
+241.6%
11,010
+205.6%
0.34%
+82.9%
Q1 2015$716,0003,6030.19%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders